InvestorsHub Logo
Followers 4
Posts 1107
Boards Moderated 0
Alias Born 02/17/2018

Re: OD3 post# 4169

Saturday, 01/19/2019 12:02:04 PM

Saturday, January 19, 2019 12:02:04 PM

Post# of 7743
4-6 weeks is the average timeline for uplisting approval if all requirements are met. Perform a Google search with key words "NASDAQ uplisting timeline" and you should come across a downloadable PDF from NASDAQ.com.

Very risky move for investors, imho.

Do some research on the subject and historical outcomes of reverse splits. Pretty scary. Whatever this company has been doing thus far has not attracted new investors no matter how much good it has going for it. Still a lot of grey and unknowns. Still no evidence that Poda vape is an actual product, GTEC deal fell apart, lot's of management turnover, no updates on phase expansions, and Gene Simmons "issues".

As I have mentioned before, monitoring for the "right" buy-in point. If the company uplisting is approved and the RS brings the share value to say $7 CAD on Gene ticker and approximately $5 on IVITF the price could easily hit $3 CAD within a week or two of NASDAQ listing.

So my buy-in point would still be on target at pre-split assessment around the $0.50 (or less) CAD range.

Doesn't take "stones" to stay in a stock that is loosing value and is constantly putting their investors at significant risk.

Good luck to everyone on your investments and decisions.